Animal models play a crucial role in biomedical research, drug discovery, and preclinical testing. The global animal model market is primarily driven by the increasing demand for more accurate and reliable models to study human diseases and test potential therapeutics. Additionally, the growing prevalence of chronic diseases and the increasing focus on personalized medicine are expected to fuel the demand for animal models. The use of genetically modified animals, particularly rodents, is also driving the market growth. However, ethical concerns surrounding animal testing and the high cost of maintaining animal facilities may hinder market growth. Nonetheless, advancements in technologies such as CRISPR/Cas9 gene editing and 3D printing are expected to open new opportunities in the animal model market.
The global Animal Model Market was valued at US$ 1,577.30 Mn in 2021 and is forecast to reach a value of US$ 2,394.30 Mn by 2028 at a CAGR of 6.0% between 2022 and 2028.
Key Companies in the Animal Model Industry:
1. Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is a global provider of research products and services for the biopharmaceutical industry. The company, founded in 1947 and headquartered in Massachusetts, has operations in over 20 countries worldwide.
2. Envigo
Envigo is a global company that provides research services and products to the biopharmaceutical industry. The company, founded in 2015, has operations in North America, Europe, and Asia. In April 2021, Envigo announced the launch of a new CRISPR-generated rat model for studying Alzheimer's disease, which will enable researchers to study the disease in a more clinically relevant animal model.
3. Eurofins Scientific SE
Eurofins Scientific SE is a Luxembourg-based company that offers analytical testing and research services to the life sciences industry. The company, founded in 1987, operates in over 50 countries worldwide. In September 2021, Eurofins Scientific announced the acquisition of VRL Laboratories, a leading provider of preclinical and clinical testing services for gene and cell therapies, vaccines, and other biologics.
4. Genoway S.A.
Genoway S.A. is a French biotechnology company that specializes in creating genetically modified research models for the biopharmaceutical industry. The company was founded in 1999 and operates in Europe, Asia, and the United States. In May 2021, Genoway announced the acquisition of Labomice, a provider of mouse model creation services, which will expand Genoway's offerings in genetic engineering and model creation.